SSTR2 (somatostatin receptor 2)

2003-02-01  

Identity

HGNC
LOCATION
17q25.1
LOCUSID
ALIAS
-

Other Information

Locus ID:

NCBI: 6752
MIM: 182452
HGNC: 11331
Ensembl: ENSG00000180616

Variants:

dbSNP: 6752
ClinVar: 6752
TCGA: ENSG00000180616
COSMIC: SSTR2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000180616ENST00000357585P30874

Expression (GTEx)

0
5
10
15
20
25
30
35
40

Pathways

PathwaySourceExternal ID
Neuroactive ligand-receptor interactionKEGGko04080
Neuroactive ligand-receptor interactionKEGGhsa04080
Gastric acid secretionKEGGko04971
Gastric acid secretionKEGGhsa04971
cAMP signaling pathwayKEGGhsa04024
cAMP signaling pathwayKEGGko04024
Signal TransductionREACTOMER-HSA-162582
Signaling by GPCRREACTOMER-HSA-372790
GPCR ligand bindingREACTOMER-HSA-500792
Class A/1 (Rhodopsin-like receptors)REACTOMER-HSA-373076
Peptide ligand-binding receptorsREACTOMER-HSA-375276
GPCR downstream signalingREACTOMER-HSA-388396
G alpha (i) signalling eventsREACTOMER-HSA-418594

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
380361572024Somatostatin receptor2 (SSTR2) expression, prognostic implications, modifications and potential therapeutic strategies associates with head and neck squamous cell carcinomas.0
383741882024Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors.0
380361572024Somatostatin receptor2 (SSTR2) expression, prognostic implications, modifications and potential therapeutic strategies associates with head and neck squamous cell carcinomas.0
383741882024Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors.0
369461822023Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic Responses.8
369898442023Somatostatin receptor 2 in 10 different types of human non-neoplastic gastrointestinal neuroendocrine cells.2
372230092023Epigenetic regulation of SST(2) expression in small intestinal neuroendocrine tumors.0
377165072023Somatostatin Receptor Type 2 and Thyroid-Stimulating Hormone Receptor Expression in Oncocytic Thyroid Neoplasms: Implications for Prognosis and Treatment.0
369461822023Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic Responses.8
369898442023Somatostatin receptor 2 in 10 different types of human non-neoplastic gastrointestinal neuroendocrine cells.2
372230092023Epigenetic regulation of SST(2) expression in small intestinal neuroendocrine tumors.0
377165072023Somatostatin Receptor Type 2 and Thyroid-Stimulating Hormone Receptor Expression in Oncocytic Thyroid Neoplasms: Implications for Prognosis and Treatment.0
346017102022The immunohistochemical expression of SSTR2A is an independent prognostic factor in meningioma.4
351841842022Diagnostic Utility of Somatostatin Receptor 2A Immunohistochemistry for Tumor-induced Osteomalacia.0
352649122022Somatostatin Receptor 2: A Potential Predictive Biomarker for Immune Checkpoint Inhibitor Treatment.0

Citation

Dessen P

SSTR2 (somatostatin receptor 2)

Atlas Genet Cytogenet Oncol Haematol. 2003-02-01

Online version: http://atlasgeneticsoncology.org/gene/42402/sstr2-(somatostatin-receptor-2)